UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060403
Receipt number R000069101
Scientific Title Effects of Ischemic Numbness Induction and Therapeutic Interventions on Sensory and Muscular Functions and Peripheral Blood Parameters in Healthy Adults
Date of disclosure of the study information 2026/01/19
Last modified on 2026/01/19 17:51:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Ischemic Numbness Induction and Therapeutic Interventions on Sensory and Muscular Functions and Peripheral Blood Parameters in Healthy Adults

Acronym

Effects of Ischemic Numbness Induction and Therapeutic Interventions on Sensory and Muscular Functions and Peripheral Blood Parameters in Healthy Adults

Scientific Title

Effects of Ischemic Numbness Induction and Therapeutic Interventions on Sensory and Muscular Functions and Peripheral Blood Parameters in Healthy Adults

Scientific Title:Acronym

Effects of Ischemic Numbness Induction and Therapeutic Interventions on Sensory and Muscular Functions and Peripheral Blood Parameters in Healthy Adults

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Numbness is a common symptom in both daily life and clinical practice, however, the physiological impact of transient numbness on sensory motor functions and peripheral blood markers in healthy individuals remains poorly understood. In this study, we will safely induce temporary numbness in healthy adults to analyze body responses in detail. Additionally, we will compare the effectiveness of three interventions stretching, light resistance training, and massage on the recovery process. Our objective is to establish a basic dataset that will contribute to more effective rehabilitation methods for managing numbness.

Basic objectives2

Others

Basic objectives -Others

N/A

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sensory function assessment, Muscle strength measurement (Handgrip strength), Blood tests (Capillary self-sampling)

Key secondary outcomes

Numbness intensity (Questionnaire)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Static stretching

Interventions/Control_2

Light intensity resistance training

Interventions/Control_3

Light massage

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

23 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy adults (aged 18 and older) who understand the study procedures and provide informed consent.

Key exclusion criteria

History of neurological, cardiovascular, or metabolic diseases (e.g., diabetes).

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Toshiharu
Middle name
Last name Yasaka

Organization

Niigata University of Health and Welfare

Division name

Department of Physical Therapy

Zip code

950-3198

Address

1398 Shimami-cho, Kita-ku, Niigata-shi, Niigata, JAPAN

TEL

025-250-1645

Email

yasaka@nuhw.ac.jp


Public contact

Name of contact person

1st name Toshiharu
Middle name
Last name Yasaka

Organization

Niigata University of Health and Welfare

Division name

Department of Physical Therapy

Zip code

950-3198

Address

1398 Shimami-cho, Kita-ku, Niigata-shi, Niigata, JAPAN

TEL

025-250-1645

Homepage URL


Email

yasaka@nuhw.ac.jp


Sponsor or person

Institute

Niigata University of Health and Welfare

Institute

Department

Personal name



Funding Source

Organization

Niigata University of Health and Welfare

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Niigata University of Health and Welfare

Address

Niigata University of Health and Welfare

Tel

025-257-4455

Email

rinri@nuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 01 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 01 Month 19 Day

Date of IRB


Anticipated trial start date

2026 Year 02 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 01 Month 19 Day

Last modified on

2026 Year 01 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069101